Sentry Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-987
Closed -$572K 439
2025
Q4
$572K Buy
987
+41
+4% +$23.2K 0.38% 44
2025
Q3
$507K Sell
946
-199
-17% -$92.6K 0.34% 46
2025
Q2
$488K Sell
1,145
-731
-39% -$306K 0.27% 71
2025
Q1
$821K Sell
1,876
-561
-23% -$304K 0.56% 27
2024
Q4
$1.27M Sell
2,437
-204
-8% -$112K 0.6% 26
2024
Q3
$1.63M Buy
2,641
+185
+8% +$110K 0.69% 22
2024
Q2
$1.36M Sell
2,456
-503
-17% -$288K 0.6% 28
2024
Q1
$1.72M Hold
2,959
0.67% 24
2023
Q4
$1.57M Buy
2,959
+718
+32% +$348K 0.67% 21
2023
Q3
$1.13M Sell
2,241
-515
-19% -$274K 0.54% 30
2023
Q2
$1.44M Sell
2,756
-839
-23% -$453K 0.54% 33
2023
Q1
$2.07M Buy
3,595
+470
+15% +$265K 0.85% 18
2022
Q4
$1.72M Buy
3,125
+326
+12% +$173K 0.76% 24
2022
Q3
$1.42M Buy
2,799
+150
+6% +$83.9K 0.67% 27
2022
Q2
$1.44M Sell
2,649
-516
-16% -$284K 0.65% 29
2022
Q1
$1.87M Sell
3,165
-503
-14% -$289K 0.6% 29
2021
Q4
$2.45M Hold
3,668
0.64% 24
2021
Q3
$2.1M Sell
3,668
-536
-13% -$294K 0.61% 27
2021
Q2
$2.12M Hold
4,204
0.54% 33
2021
Q1
$1.92M Sell
4,204
-21,158
-83% -$10.1M 0.53% 39
2020
Q4
$11.8M Sell
25,362
-134
-0.5% -$62.8K 0.59% 33
2020
Q3
$11.3M Buy
25,496
+2,469
+11% +$1.02M 0.63% 31
2020
Q2
$8.34M Sell
23,027
-2,441
-10% -$818K 0.51% 42
2020
Q1
$7.22M Buy
25,468
+395
+2% +$125K 0.53% 48
2019
Q4
$8.14M Buy
25,073
+486
+2% +$147K 0.49% 46
2019
Q3
$7.16M Hold
24,587
0.47% 52
2019
Q2
$7.22M Buy
24,587
+466
+2% +$128K 0.48% 46
2019
Q1
$6.6M Sell
24,121
-1,490
-6% -$371K 0.46% 52
2018
Q4
$5.73M Sell
25,611
-655
-2% -$154K 0.42% 57
2018
Q3
$6.41M Sell
26,266
-134
-0.5% -$30.8K 0.39% 64
2018
Q2
$5.47M Sell
26,400
-2,611
-9% -$554K 0.36% 64
2018
Q1
$5.99M Sell
29,011
-2,786
-9% -$585K 0.36% 68
2017
Q4
$6.04M Buy
31,797
+1,484
+5% +$284K 0.33% 79
2017
Q3
$5.74M Hold
30,313
0.22% 80
2017
Q2
$5.29M Hold
30,313
0.21% 87
2017
Q1
$4.66M Sell
30,313
-1,412
-4% -$216K 0.19% 94
2016
Q4
$4.48M Buy
31,725
+640
+2% +$94.4K 0.19% 95
2016
Q3
$4.94M Buy
31,085
+1,040
+3% +$160K 0.22% 80
2016
Q2
$4.44M Hold
30,045
0.19% 86
2016
Q1
$4.25M Hold
30,045
0.19% 89
2015
Q4
$4.26M Buy
30,045
+7,367
+32% +$983K 0.2% 87
2015
Q3
$2.77M Hold
22,678
0.14% 126
2015
Q2
$2.94M Sell
22,678
-1,315
-5% -$171K 0.14% 135
2015
Q1
$3.22M Sell
23,993
-750
-3% -$96.7K 0.15% 112
2014
Q4
$3.1M Buy
24,743
+5,500
+29% +$669K 0.15% 118
2014
Q3
$2.34M Sell
19,243
-2,372
-11% -$288K 0.12% 134
2014
Q2
$2.55M Sell
21,615
-8,185
-27% -$963K 0.13% 129
2014
Q1
$3.58M Sell
29,800
-16,100
-35% -$1.91M 0.19% 81
2013
Q4
$5.11M Sell
45,900
-23,900
-34% -$2.38M 0.28% 60
2013
Q3
$6.43M Buy
69,800
+7,800
+13% +$705K 0.38% 38
2013
Q2
$5.25M Buy
+62,000
New +$5.16M 0.3% 29

Other funds holding TMO

Sentry Investment Management's TMO Position: Q1 2026 in Review

Sentry Investment Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 987 shares — an estimated $572K sold.

Sentry Investment Management first reported a position in TMO in Q2 2013 and held it in 51 quarters. The position peaked at $11.8M in Q4 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Sentry Investment Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 987 Thermo Fisher Scientific shares in Q1 2026, an estimated $572K.
  • Sentry Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 51 quarters.
  • Sentry Investment Management's Thermo Fisher Scientific position peaked at $11.8M in Q4 2020.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.